Evidence map›Paper›PMID 29212229›Full record

ArticleOncotarget2017

Solid formulation of a supersaturable self-microemulsifying drug delivery system for valsartan with improved dissolution and bioavailability.

Dong Woo Yeom, Bo Ram Chae, Jin Han Kim, Jun Soo Chae, Dong Jun Shin, Chang Hyun Kim, Sung Rae Kim, Ji Ho Choi, Seh Hyon Song, Dongho Oh and 2 more

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Polyphenols in wound healing: unlocking prospects with clinical applications.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dong Woo YeomCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Bo Ram ChaeCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Jin Han KimCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Jun Soo ChaeCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Dong Jun ShinCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Chang Hyun KimCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Sung Rae KimCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Ji Ho ChoiCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Seh Hyon SongDaewon Pharm. Co., Ltd, Seoul 04994, Republic of Korea.
Dongho OhDaewon Pharm. Co., Ltd, Seoul 04994, Republic of Korea.
Se Il SohnDaewon Pharm. Co., Ltd, Seoul 04994, Republic of Korea.
Young Wook ChoiCollege of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to improve the dissolution and oral bioavailability of valsartan (VST), and reduce the required volume for treatment, we previously formulated a supersaturable self-microemulsifying drug delivery system (SuSMEDDS) composed of VST (80 mg), Capmul

Indexed as

optimizationSMEDDSsolid carriertabletvalsartan

Identifiers

PMID29212229
PMCPMC5706875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.